Plasma cytokines and chemokines in primary graft dysfunction post-lung transplantation

American Journal of Transplantation

Volumn 9, Issue 2, 2009, Pages 389-396

  Hoffman, S A ^a   Wang, L ^b   Shah, C V ^a   Ahya, V N ^a   Pochettino, A ^a   Olthoff, K ^a   Shaked, A ^a   Wille, K ^c   Lama, V N ^d   Milstone, A ^e   Ware, L B ^e   Orens, J ^f   Weinacker, A ^g   Demissie, E ^a   Bellamy, S ^a   Kawut, S M ^h,i   Hancock, W W ^b   Christie, J D ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c University of Alabama at Birmingham   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e VANDERBILT UNIVERSITY   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g STANFORD UNIVERSITY   (United States)

^h New York Presbyterian Columbia University Medical Center   (United States)

ⁱ Department of Medicine   (United States)

Author keywords

Chemokines; Cytokines; Lung transplantation; Primary graft dysfunction; Reperfusion injury

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CHEMOKINE; CINTREDEKIN BESUDOTOX; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 2 RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE MARKER; EFFECTOR CELL; FEMALE; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; UPREGULATION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINES; COHORT STUDIES; CYTOKINES; FEMALE; GRAFT REJECTION; HUMANS; INFLAMMATION MEDIATORS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PRIMARY GRAFT DYSFUNCTION; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58849086671     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2008.02497.x     Document Type: Article

References (24)

1. Christie JD, Bavaria JE, Palevsky HI et al. Primary graft failure following lung transplantation. Chest 1998 114 : 51 60.
2. King RC, Binns OA, Rodriguez F et al. Reperfusion injury significantly impacts clinical outcome after pulmonary transplantation. Ann Thorac Surg 2000 69 : 1681 1685.
3. Christie JD, Kotloff RM, Pochettino A et al. Clinical risk factors for primary graft failure following lung transplantation. Chest 2003 124 : 1232 1241.
4. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999 340 : 1081 1091.
5. De Perrot M, Sekine Y, Fischer S et al. Interleukin-8 release during early reperfusion predicts graft function in human lung transplantation. Am J Respir Crit Care Med 2002 165 : 211 215.
6. Christie JD, Sager JS, Kimmel SE et al. Impact of primary graft failure on outcomes following lung transplantation. Chest 2005 127 : 161 165.
7. Arcasoy SM, Fisher A, Hachem RR, Scavuzzo M, Ware LB. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part V: Predictors and outcomes. J Heart Lung Transplant 2005 24 : 1483 1488.
8. Christie JD, Kotloff RM, Ahya VN et al. The effect of primary graft dysfunction on survival after lung transplantation. Am J Respir Crit Care Med 2005 171 : 1312 1316.
9. Christie JD, Van Raemdonck D, de Perrot M et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part I: Introduction and methods. J Heart Lung Transplant 2005 24 : 1451 1453.
10. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part II: Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005 24 : 1454 1459.
11. de Perrot M, Bonser RS, Dark J et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part III: Donor-related risk factors and markers. J Heart Lung Transplant 2005 24 : 1460 1467.
12. de Perrot M, Liu M, Waddell TK, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003 167 : 490 511.
13. Barr ML, Kawut SM, Whelan TP et al. Report of the ISHLT Working Group on Primary Lung Graft Dysfunction part IV: Recipient-related risk factors and markers. J Heart Lung Transplant 2005 24 : 1468 1482.
14. Serrick C, Adoumie R, Giaid A, Shennib H. The early release of interleukin-2, tumor necrosis factor-alpha and interferon-gamma after ischemia reperfusion injury in the lung allograft. Transplantation 1994 58 : 1158 1162.
15. Naidu BV, Farivar AS, Woolley SM, Grainger D, Verrier ED, Mulligan MS. Novel broad-spectrum chemokine inhibitor protects against lung ischemia-reperfusion injury. J Heart Lung Transplant 2004 23 : 128 134.
16. Wacholder S. Design issues in case control studies. Stat Methods Med Res 1995 4 : 293 309.
17. Christie JD, Robinson N, Ware LB et al. Association of protein C and type 1 plasminogen activator inhibitor with primary graft dysfunction. Am J Respir Crit Care Med 2007 175 : 69 74.
18. Covarrubias M, Ware LB, Kawut SM et al. Plasma intercellular adhesion molecule-1 and von Willebrand factor in primary graft dysfunction after lung transplantation. Am J Transplant 2007 7 : 2573 2578.
19. Frangogiannis NG. The role of the chemokines in myocardial ischemia and reperfusion. Curr Vasc Pharmacol 2004 2 : 163 174.
20. Tatapudi RR, Muthukumar T, Dadhania D et al. Noninvasive detection of renal allograft inflammation by measurements of mRNA for IP-10 and CXCR3 in urine. Kidney Int 2004 65 : 2390 2397.
21. Melter M, Exeni A, Reinders ME et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001 104 : 2558 2564.
22. Hancock WW, Gao W, Csizmadia V, Faia KL, Shemmeri N, Luster AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001 193 : 975 980.
23. Hancock WW, Lu B, Gao W et al. Requirement of the chemokine receptor CXCR3 for acute allograft rejection. J Exp Med 2000 192 : 1515 1520.
24. Mathur A, Baz M, Staples ED et al. Cytokine profile after lung transplantation: Correlation with allograft injury. Ann Thorac Surg 2006 81 : 1844 1849 discussion 1849-1850.